Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
Abstract Background Bacteria belonging to the Burkholderia cepacia complex (Bcc) are an important cause of chronic respiratory tract infections in cystic fibrosis patients. Intrinsic resistance to a wide range of antimicrobial agents, including a variety of β-lactam antibiotics, is frequently observ...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-11-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13756-016-0142-3 |
id |
doaj-f71127a8a5974fffbe20396faa988c7b |
---|---|
record_format |
Article |
spelling |
doaj-f71127a8a5974fffbe20396faa988c7b2020-11-24T21:53:27ZengBMCAntimicrobial Resistance and Infection Control2047-29942016-11-01511810.1186/s13756-016-0142-3Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex speciesAnnelien Everaert0Tom Coenye1Laboratory of Pharmaceutical Microbiology, Ghent UniversityLaboratory of Pharmaceutical Microbiology, Ghent UniversityAbstract Background Bacteria belonging to the Burkholderia cepacia complex (Bcc) are an important cause of chronic respiratory tract infections in cystic fibrosis patients. Intrinsic resistance to a wide range of antimicrobial agents, including a variety of β-lactam antibiotics, is frequently observed in Bcc strains. Resistance to β-lactams is most commonly mediated by efflux pumps, alterations in penicillin-binding proteins or the expression of β-lactamases. β-lactamase inhibitors are able to restore the in vitro activity of β-lactam molecules against a variety of Gram-negative species, but the effect of these inhibitors on the activity of β-lactam treatment against Bcc species is still poorly investigated. Methods In the present study, the susceptibility of a panel of Bcc strains was determined towards the β-lactam antibiotics ceftazidime, meropenem, amoxicillin, cefoxitin, cefepime and aztreonam; alone or in combination with a β-lactamase inhibitor (clavulanic acid, sulbactam, tazobactam and avibactam). Consequently, β-lactamase activity was determined for active β-lactam/β-lactamase inhibitor combinations. Results Clavulanic acid had no effect on minimum inhibitory concentrations, but addition of sulbactam, tazobactam or avibactam to ceftazidime, amoxicillin, cefoxitin, cefepime or aztreonam leads to increased susceptibility (at least 4-fold MIC-decrease) in some Bcc strains. The effect of β-lactamase inhibitors on β-lactamase activity is both strain- and/or antibiotic-dependent, and other mechanisms of β-lactam resistance (besides production of β-lactamases) appear to be important. Conclusions Considerable differences in susceptibility of Bcc strains to β-lactam antibiotics were observed. Results obtained in the present study suggest that resistance of Bcc strains against β-lactam antibiotics is mediated by both β-lactamases and non-β-lactamase-mediated resistance mechanisms.http://link.springer.com/article/10.1186/s13756-016-0142-3Burkholderia cepacia complexResistanceβ-lactamβ-lactamaseβ-lactamase inhibitors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Annelien Everaert Tom Coenye |
spellingShingle |
Annelien Everaert Tom Coenye Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species Antimicrobial Resistance and Infection Control Burkholderia cepacia complex Resistance β-lactam β-lactamase β-lactamase inhibitors |
author_facet |
Annelien Everaert Tom Coenye |
author_sort |
Annelien Everaert |
title |
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species |
title_short |
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species |
title_full |
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species |
title_fullStr |
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species |
title_full_unstemmed |
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species |
title_sort |
effect of β-lactamase inhibitors on in vitro activity of β-lactam antibiotics against burkholderia cepacia complex species |
publisher |
BMC |
series |
Antimicrobial Resistance and Infection Control |
issn |
2047-2994 |
publishDate |
2016-11-01 |
description |
Abstract Background Bacteria belonging to the Burkholderia cepacia complex (Bcc) are an important cause of chronic respiratory tract infections in cystic fibrosis patients. Intrinsic resistance to a wide range of antimicrobial agents, including a variety of β-lactam antibiotics, is frequently observed in Bcc strains. Resistance to β-lactams is most commonly mediated by efflux pumps, alterations in penicillin-binding proteins or the expression of β-lactamases. β-lactamase inhibitors are able to restore the in vitro activity of β-lactam molecules against a variety of Gram-negative species, but the effect of these inhibitors on the activity of β-lactam treatment against Bcc species is still poorly investigated. Methods In the present study, the susceptibility of a panel of Bcc strains was determined towards the β-lactam antibiotics ceftazidime, meropenem, amoxicillin, cefoxitin, cefepime and aztreonam; alone or in combination with a β-lactamase inhibitor (clavulanic acid, sulbactam, tazobactam and avibactam). Consequently, β-lactamase activity was determined for active β-lactam/β-lactamase inhibitor combinations. Results Clavulanic acid had no effect on minimum inhibitory concentrations, but addition of sulbactam, tazobactam or avibactam to ceftazidime, amoxicillin, cefoxitin, cefepime or aztreonam leads to increased susceptibility (at least 4-fold MIC-decrease) in some Bcc strains. The effect of β-lactamase inhibitors on β-lactamase activity is both strain- and/or antibiotic-dependent, and other mechanisms of β-lactam resistance (besides production of β-lactamases) appear to be important. Conclusions Considerable differences in susceptibility of Bcc strains to β-lactam antibiotics were observed. Results obtained in the present study suggest that resistance of Bcc strains against β-lactam antibiotics is mediated by both β-lactamases and non-β-lactamase-mediated resistance mechanisms. |
topic |
Burkholderia cepacia complex Resistance β-lactam β-lactamase β-lactamase inhibitors |
url |
http://link.springer.com/article/10.1186/s13756-016-0142-3 |
work_keys_str_mv |
AT annelieneveraert effectofblactamaseinhibitorsoninvitroactivityofblactamantibioticsagainstburkholderiacepaciacomplexspecies AT tomcoenye effectofblactamaseinhibitorsoninvitroactivityofblactamantibioticsagainstburkholderiacepaciacomplexspecies |
_version_ |
1725872123309719552 |